Dublin, Feb. 14, 2019 (GLOBE NEWSWIRE) — The “Cell Counting Market by Product (Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer), Consumables), End User (Pharmaceutical, Hospital, Research) – Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.
The cell counting market is expected to reach USD 12.32 billion by 2023 from an estimated USD 8.84 billion in 2018, at a CAGR of 6.8%.
Growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers are some of the factors driving the growth of this market. However, the high cost of advanced cell counting systems and product recalls for instruments such as hematology analyzers are restraining the growth of this market to a certain extent.
The consumables segment is expected to register the highest CAGR during the forecast period.
On the basis of product, the cell counting market is segmented into consumables and instruments. The consumables segment is further subsegmented into media, sera, & reagents; assay kits; microplates; accessories; and other consumables. The consumables segment is expected to register the highest CAGR during the forecast period.
This growth can be attributed to the use of various consumables in stem cell and cancer research along with growing applications in quality control procedures in various industries such as food and beverage, pharmaceutical, and biotechnology products manufacturing, and in the field of environmental monitoring and water treatment.
The clinical & diagnostic applications segment to witness the highest growth during the forecast period.
On the basis of application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. The clinical and diagnostic applications segment is expected to witness the highest CAGR owing to the fact that various cell counting instruments are utilized in the diagnosis of cancer, blood-related disorders, infectious diseases, and HIV/AIDS. The increasing prevalence of these diseases will support the growth of this market segment.
The hospitals segment is expected to register the highest CAGR during the forecast period.
Based on end user, the cell counting market is segmented into research institutes, hospitals, clinical laboratories, pharmaceutical & biotechnology companies, and other end users. The hospitals segment is expected to register the highest CAGR during the forecast period. This can be attributed to the adoption of cell counting equipment for the diagnosis and treatment of several diseases along with the continuous consumption of consumables.
APAC is projected to witness the highest growth during the forecast period.
North America to account for the largest share of the global cell counting market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.
Key Topics Covered:
1 Cell Counting Market: Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Stakeholders
1.6 Limitations
2 Cell Counting Market: Research Methodology
2.1 Research Approach
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Cell Counting Market: Executive Summary
4 Cell Counting Market: Premium Insights
4.1 Cell Counting Market Overview
4.2 Cell Counting Market: Geographic Growth Opportunities
4.3 Regional Mix: Cell Counting Market (2018-2023)
4.4 Asia Pacific: Cell Counting Instruments Market, By Type (2017)
4.5 Cell Counting Market: Developed vs Developing Markets
5 Cell Counting Market: Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Incidence of Target Diseases and Blood Disorders
5.2.1.2 Development of Enhanced Solutions and Improved Image Analysis
5.2.1.3 Growing Use of High-Throughput Flow Cytometry and Automated Hematology Analyzers
5.2.2 Market Restraints
5.2.2.1 High Cost of Advanced Cell Counting Systems
5.2.2.2 Product Recalls of Hematology Analyzers
5.2.3 Market Opportunities
5.2.3.1 Growing Focus on Stem Cell Research
5.2.3.2 Emerging Economies
5.2.4 Market Challenges
5.2.4.1 Inadequate Infrastructure for Research in Emerging Countries
5.2.4.2 Dearth of Skilled Professionals in Clinical Laboratories
6 Cell Counting Market: Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Increasing Demand for Small Automated Cell Counting Instruments
6.2.2 Integration of Hematology Analyzers With Flow Cytometry
6.3 Value Chain Analysis
6.4 Parent Market Analysis
7 Cell Counting Market, By Product
7.1 Introduction
7.2 Consumables
7.2.1 Media, Sera, & Reagents
7.2.2 Assay Kits
7.2.3 Microplates
7.2.4 Accessories
7.2.5 Other Consumables
7.3 Instruments
7.3.1 Spectrophotometers
7.3.1.1 Single-Mode Readers
7.3.1.2 Multi-Mode Readers
7.3.2 Flow Cytometers
7.3.3 Hematology Analyzers
7.3.3.1 Fully Automated Analyzers
7.3.3.2 Semi-Automated Analyzers
7.3.4 Cell Counters
7.3.4.1 Automated Cell Counters
7.3.4.2 Hemocytometers/Manual Cell Counters
8 Cell Counting Market, By Application
8.1 Introduction
8.2 Research Applications
8.3 Clinical & Diagnostic Applications
8.4 Industrial Applications
9 Cell Counting Market, By End User
9.1 Introduction
9.2 Research Institutes
9.3 Pharmaceutical & Biotechnology Companies
9.4 Hospitals
9.5 Clinical Laboratories
9.6 Other End Users
10 Cell Counting Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.6 Middle East & Africa
11 Cell Counting Market: Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.2.1 Market Share Analysis: Global Cell Counting Market
11.3 Product Portfolio Matrix
11.4 Competitive Situation and Trends
11.4.1 Product Launches
11.4.2 Expansions
11.4.3 Acquisitions
11.4.4 Other Strategies
12 Cell Counting Market: Company Profiles
12.1 Danaher Corporation
12.2 Thermo Fisher Scientific
12.3 Becton, Dickinson and Company
12.4 Merck
12.5 Bio-Rad Laboratories
12.6 Ge Healthcare
12.7 Perkinelmer
12.8 Biotek Instruments
12.9 Agilent Technologies
12.10 Tecan
12.11 Abbott Laboratories
12.12 Siemens Healthineers
12.13 F. Hoffmann-La Roche
12.14 Sysmex Corporation
12.15 Horiba
For more information about this report visit https://www.researchandmarkets.com/research/hcnkcf/global_cell?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology
